Unknowingly, each day we put ourselves in harm's way of potential exposure to contaminants and toxins that have the ability to adversely affect our own health. Whether on the job or in the home, it is important to understand what is surrounding us, and how it affects us. Toxic substances can be difficult to pinpoint, since they can be found in a number of places, including water sources, walls, construction materials and often the air. As seasons change and the weather and lifestyles follow, spring is an important time to educate ourselves on hazards around us.
The road to the NCAA® Men’s Basketball Championship ended in Minneapolis this year. Excitement surrounding the commencement of the festivities was palpable on Friday, April 5th as thousands of fans filed in the U.S. Bank Stadium to cheer on their team. But, regardless if they had come to support Auburn, Michigan State, Texas Tech, or Virginia, everyone cheered together in support of the players that took to the floor for the INFINITI Hardwood Heroes Basketball Game benefitting Coaches vs Cancer.
In the past three decades, in vitro fertilization (IVF) has gone from an experimental procedure to being more common. Pregnancies enabled by IVF frequently have more difficulties, with children born earlier and smaller even among singleton births.
April is National Testicular Cancer Awareness Month. In 2019, the American Cancer Society estimates there will be 9,560 new cases of testicular cancer in the United States.
Arpit Rao, M.D., a testicular cancer expert with the Masonic Cancer Center and the University of Minnesota Medical School, answers questions on the symptoms, treatment and screening for testicular cancer.
Author: | MARCH 29, 2019
More than 16,000 women die from ovarian cancer each year in the United States. Ovarian cancer is often called the "silent killer" because the symptoms are so vague that women are often not diagnosed with ovarian cancer until the disease has progressed to advanced stages.
Currently, no blood test exists that is adequately sensitive or specific enough to be used to screen women in the general population for ovarian cancer. Studies have shown that using just one protein biomarker at a time is not sufficient to screen women's blood for ovarian cancer.
March 13, 2019 (Austin, Minnesota) – For most people, the only thing worse than hearing the diagnosis "cancer" is hearing that it has returned. Dr. Ilana Chefetz, leader of The Hormel Institute's "Cancer Stem Cells and Necroptosis" lab, today published new discoveries about ovarian cancer chemo resistance and recurrence in the top journal Cell Reports. Her research project included collaborations with Drs. David Lombard, Charles Landen, Thomas D. Hurley, Scott D. Larsen and Ronald J.